Esophageal cancer is the fourth most common cancer in China, with a total of 477,900 new cases and 375,000 deaths projected to occur in 2015, and it is more common in males than in females ( Chen et al., 2016 x Chen et al., 2016 Chen, W., Zheng, R., Baade, P.D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X.Q., and He, J. Cancer statistics in China, 2015. CA Cancer J. Clin. 2016; 66: 115–132 Crossref | PubMed | Scopus (5149) | Google Scholar See all References Chen et al., 2016 ). The two major histological types of esophageal cancer, viz. esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC), which are distinct entities affected by diverse risk profiles, are now experiencing a global epidemiologic shift in recent decades ( Brown and Devesa, 2002 x Brown and Devesa, 2002 Brown, L.M. and Devesa, S.S. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg. Oncol. Clin. N. Am. 2002; 11: 235–256 Abstract | Full Text | Full Text PDF | PubMed | Scopus (367) | Google Scholar See all References , Alexandre et al., 2014 x Alexandre et al., 2014 Alexandre, L., Long, E., and Beales, I.L. Pathophysiological mechanisms linking obesity and esophageal adenocarcinoma. World J. Gastrointest. Pathophysiol. 2014; 5: 534–549 Crossref | PubMed | Google Scholar See all References , Rustgi and El-Serag, 2014 x Rustgi and El-Serag, 2014 Rustgi, A.K. and El-Serag, H.B. Esophageal carcinoma. N. Engl. J. Med. 2014; 371: 2499–2509 Crossref | PubMed | Scopus (364) | Google Scholar See all References ). Remarkably, compared with the most prevalent EAC in the U.S. and many Western countries, ESCC is the dominant histological type in China, and accounts for over 90% of esophageal cancer cases ( Torre et al., 2015 x Torre et al., 2015 Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J., and Jemal, A. Global cancer statistics, 2012. CA Cancer J. Clin. 2015; 65: 87–108 Crossref | PubMed | Scopus (13348) | Google Scholar See all References , Arnold et al., 2015 x Arnold et al., 2015 Arnold, M., Soerjomataram, I., Ferlay, J., and Forman, D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2015; 64: 381–387 Crossref | PubMed | Scopus (304) | Google Scholar See all References ). Despite recent substantial advances in clinical diagnostic and therapeutic tools ( Sawayama et al., 2014 x Sawayama et al., 2014 Sawayama, H., Ishimoto, T., Watanabe, M., Yoshida, N., Sugihara, H., Kurashige, J., Hirashima, K., Iwatsuki, M., Baba, Y., Oki, E., Morita, M., Shiose, Y., and Baba, H. Small molecule agonists of PPAR-gamma exert therapeutic effects in esophageal cancer. Cancer Res. 2014; 74: 575–585 Crossref | PubMed | Scopus (24) | Google Scholar See all References , Messager et al., 2016 x Messager et al., 2016 Messager, M., Warlaumont, M., Renaud, F., Marin, H., Branche, J., Piessen, G., and Mariette, C. Recent improvements in the management of esophageal anastomotic leak after surgery for cancer. Eur J. Surg. Oncol. 2017; 43: 258–269 Abstract | Full Text | Full Text PDF | PubMed | Scopus (22) | Google Scholar See all References ), esophageal cancer exhibits an extremely poor prognosis with the 5-year survival rate of around 20% in China, mainly because it grows aggressively and is often diagnosed at an advanced stage ( Zeng et al., 2015 x Zeng et al., 2015 Zeng, H., Zheng, R., Guo, Y., Zhang, S., Zou, X., Wang, N., Zhang, L., Tang, J., Chen, J., Wei, K., Huang, S., Wang, J., Yu, L., Zhao, D., Song, G., Shen, Y., Yang, X., Gu, X., Jin, F., Li, Q., Li, Y., Ge, H., Zhu, F., Dong, J., Guo, G., Wu, M., Du, L., Sun, X., He, Y., Coleman, M.P., Baade, P., Chen, W., and Yu, X.Q. Cancer survival in China, 2003–2005: a population-based study. Int. J. Cancer. 2015; 136: 1921–1930 Crossref | PubMed | Scopus (239) | Google Scholar See all References , Tseng et al., 2015 x Tseng et al., 2015 Tseng, R.C., Chang, J.M., Chen, J.H., Huang, W.R., Tang, Y.A., Kuo, I.Y., Yan, J.J., Lai, W.W., and Wang, Y.C. Deregulation of SLIT2-mediated Cdc42 activity is associated with esophageal cancer metastasis and poor prognosis. J. Thorac. Oncol. 2015; 10: 189–198 Abstract | Full Text | Full Text PDF | PubMed | Scopus (15) | Google Scholar See all References , Klein and Stoecklein, 2009 x Klein and Stoecklein, 2009 Klein, C.A. and Stoecklein, N.H. Lessons from an aggressive cancer: evolutionary dynamics in esophageal carcinoma. Cancer Res. 2009; 69: 5285–5288 Crossref | PubMed | Scopus (39) | Google Scholar See all References ). One of the practical choices to improve overall survival is the identification of easy-to-obtain markers with prognostic significance for esophageal cancer by formulating more targeted and effective management strategies for high risk patients, such as metabolic profiling markers ( Yakoub et al., 2010 x Yakoub et al., 2010 Yakoub, D., Keun, H.C., Goldin, R., and Hanna, G.B. Metabolic profiling detects field effects in nondysplastic tissue from esophageal cancer patients. Cancer Res. 2010; 70: 9129–9136 Crossref | PubMed | Scopus (33) | Google Scholar See all References Yakoub et al., 2010 ).